Unnamed: 0,title,date,stock,sentiment
1095355.0,"Rockwell Medical, Inc. Files New Drug Submission With Health Canada For Marketing Approval Of Triferic AVNU",2020-05-26 07:04:00-04:00,RMTI,positive
1095356.0,"Rockwell Medical Q1 EPS $(0.120), Inline, Sales $15.900M Beat $15.800M Estimate",2020-05-11 16:24:00-04:00,RMTI,neutral
1095357.0,"The Week Ahead In Biotech: Virtual Conference Presentations, Clovis PDUFA Date In The Spotlight",2020-05-10 15:40:00-04:00,RMTI,neutral
1095358.0,17 Healthcare Stocks Moving In Friday's Pre-Market Session,2020-05-08 07:50:00-04:00,RMTI,neutral
1095359.0,"The Daily Biotech Pulse: FDA Approves Novartis Lung Cancer Drug, 2-Way Contest Emerging For Tetraphase Pharma, Dexcom To Join S&P 500",2020-05-07 07:41:00-04:00,RMTI,negative
1095360.0,The Week Ahead In Biotech: Smid-Cap Earnings News Flow Picks Up Pace,2020-05-03 08:45:00-04:00,RMTI,neutral
1095361.0,"Rockwell Medical Names Russell Ellison Pres, CEO",2020-04-20 08:46:00-04:00,RMTI,neutral
1095362.0,"HC Wainwright & Co. Maintains Buy on Rockwell Medical, Lowers Price Target to $9",2020-04-07 13:03:00-04:00,RMTI,negative
1095363.0,Shares of several healthcare companies are trading higher as markets gain amid optimism that coronavirus cases in several U.S. hotspots may be peaking. A sooner peak could mean a sooner return to economic activity.,2020-04-06 11:47:00-04:00,RMTI,positive
1095364.0,Rockwell Medical Appoints Robert S. Radie to Board of Directors,2020-03-31 16:35:00-04:00,RMTI,neutral
1095365.0,"Rockwell Medical Reports Receives FDA Approval For Triferic AVNU IV Formulation Of Triferic For Replacement Of Iron, Maintenance Of Hemoglobin In Hemodialysis Patients",2020-03-27 11:22:00-04:00,RMTI,positive
1095366.0,"The Week Ahead In Biotech: Bristol-Myers, Rockwell Medical Await FDA Decisions, COVID-19 Updates In Focus",2020-03-22 14:25:00-04:00,RMTI,positive
1095367.0,Rockwell Medical Reiterates Medical Resource Acquisition Group Failed To Properly Deliver Notice Of Director Nominations,2020-03-20 08:32:00-04:00,RMTI,negative
1095368.0,"The Daily Biotech Pulse: Setback For DBV In Peanut Allergy Patch Review, Roche Starts Coronavirus Test Shipment, Regeneron Aims For 'Cocktail' COVID-19 Treatment",2020-03-17 08:48:00-04:00,RMTI,neutral
1095369.0,"Rockwell Medical, Inc. Announces $35M Debt Financing Agreement With Innovatus Capital Partners, LLC",2020-03-17 06:53:00-04:00,RMTI,positive
1095370.0,144 Biggest Movers From Friday,2020-03-16 05:03:00-04:00,RMTI,neutral
1095371.0,Shares of several healthcare companies are trading higher as the market rebounds following Thursday's selloff. NOTE: Since the coronavirus outbreak the healthcare sector has been extremely volatile.,2020-03-13 09:29:00-04:00,RMTI,positive
1095372.0,136 Biggest Movers From Yesterday,2020-03-13 05:20:00-04:00,RMTI,neutral
1095373.0,"Rockwell Medical Q4 EPS $(0.11) Beats $(0.12) Estimate, Sales $15.5M Miss $16.22M Estimate",2020-03-12 16:27:00-04:00,RMTI,negative
1095374.0,90 Stocks Moving In Thursday's Mid-Day Session,2020-03-12 12:21:00-04:00,RMTI,neutral
1095375.0,Shares of several healthcare companies are trading lower as equities sell off amid continued global coronavirus concerns. The virus has caused global economic disruption and negatively impacted stocks across sectors.,2020-03-12 09:26:00-04:00,RMTI,negative
1095376.0,"The Daily Biotech Pulse: AstraZeneca Faces Setback In Ovarian Cancer Study, Mallinckrodt To Explore COVID-19 Treatment, Imara IPO",2020-03-12 07:37:00-04:00,RMTI,negative
1095377.0,"The Daily Biotech Pulse: Mesoblast To Test Candidate On Coronavirus Symptoms, Proxy Battle Ahead For Rockwell Medical, Glaukos to Join S&P SmallCap 600 Index",2020-03-10 09:19:00-04:00,RMTI,negative
1095378.0,"Rockwell Medical, Inc. Offered $15M By Medical Resource Acquisition Group, LLC",2020-03-09 16:54:00-04:00,RMTI,neutral
1095379.0,"The Week Ahead In Biotech (March 8-14): Bristol-Myers Awaits FDA Nod For Liver Cancer Combo Therapy, Earnings Flow Continues",2020-03-08 16:14:00-04:00,RMTI,negative
1095380.0,108 Biggest Movers From Yesterday,2020-03-03 04:57:00-05:00,RMTI,neutral
1095381.0,Attention Biotech Investors: Mark Your Calendar For These March PDUFA Dates,2020-03-02 16:46:00-05:00,RMTI,neutral
1095382.0,25 Healthcare Stocks Moving In Monday's Pre-Market Session,2020-02-24 07:39:00-05:00,RMTI,neutral
1095383.0,25 Healthcare Stocks Moving In Wednesday's Pre-Market Session,2020-02-19 08:10:00-05:00,RMTI,neutral
1095384.0,80 Biggest Movers From Yesterday,2020-02-19 04:28:00-05:00,RMTI,neutral
1095385.0,94 Biggest Movers From Yesterday,2020-02-12 05:13:00-05:00,RMTI,neutral
1095386.0,80 Biggest Movers From Yesterday,2020-02-11 04:44:00-05:00,RMTI,neutral
1095387.0,58 Stocks Moving In Monday's Mid-Day Session,2020-02-10 12:14:00-05:00,RMTI,neutral
1095388.0,68 Biggest Movers From Yesterday,2020-02-05 05:56:00-05:00,RMTI,neutral
1095389.0,Mid-Afternoon Market Update: NASDAQ Rises Over 2%; Myomo Shares Spike Higher,2020-02-04 14:23:00-05:00,RMTI,positive
1095390.0,55 Stocks Moving In Tuesday's Mid-Day Session,2020-02-04 12:35:00-05:00,RMTI,neutral
1095391.0,Mid-Day Market Update: Allot Surges After Q4 Results; Rockwell Medical Shares Plunge,2020-02-04 12:10:00-05:00,RMTI,positive
1095392.0,Rockwell Medical Prices ~3.191M Share Common Stock Offering For Gross Proceeds $7.5M,2020-02-04 09:22:00-05:00,RMTI,negative
1095393.0,"The Daily Biotech Pulse: EyePoint In-Licenses Eye Disorder Drug, BioMarin CFO Quits, Rockwell Medical To Offer Shares",2020-02-04 07:51:00-05:00,RMTI,negative
1095394.0,11 Healthcare Stocks Moving In Tuesday's Pre-Market Session,2020-02-04 07:43:00-05:00,RMTI,neutral
1095395.0,3 Drug Manufacturers—Specialty & Generic Stocks Moving In Tuesday's Pre-Market Session,2020-02-04 07:41:00-05:00,RMTI,neutral
1095396.0,33 Stocks Moving in Tuesday's Pre-Market Session,2020-02-04 07:24:00-05:00,RMTI,neutral
1095397.0,"12 Stocks To Watch For February 4, 2020",2020-02-04 04:42:00-05:00,RMTI,neutral
1095398.0,7 Stocks Moving In Monday's After Hours,2020-02-03 16:24:00-05:00,RMTI,neutral
1095399.0,Rockwell Medical shares are trading lower after the company announced a proposed common stock offering of no disclosed size.,2020-02-03 16:04:00-05:00,RMTI,negative
1095400.0,Rockwell Medical Announces Proposed Common Stock Offering; Size Not Disclosed,2020-02-03 16:02:00-05:00,RMTI,neutral
1095401.0,20 Specialty & Generic Drug Manufacturer Stocks Moving In Monday's Session,2020-01-27 12:26:00-05:00,RMTI,neutral
1095402.0,14 Drug Manufacturers—Specialty & Generic Stocks Moving In Thursday's Session,2020-01-23 12:52:00-05:00,RMTI,neutral
1095403.0,75 Biggest Movers From Yesterday,2020-01-16 04:37:00-05:00,RMTI,neutral
1095404.0,36 Stocks Moving In Wednesday's Mid-Day Session,2020-01-15 12:07:00-05:00,RMTI,neutral
1095405.0,"The Daily Biotech Pulse: Nektar Withdraws Opioid Pain Drug NDA, Galapagos Takes Stake In Fibrocor, Integra Lifesciences Lowers Q4 Guidance",2020-01-15 08:22:00-05:00,RMTI,negative
1095406.0,34 Healthcare Stocks Moving In Wednesday's Pre-Market Session,2020-01-15 08:10:00-05:00,RMTI,neutral
1095407.0,21 Stocks Moving in Wednesday's Pre-Market Session,2020-01-15 07:43:00-05:00,RMTI,neutral
1095408.0,58 Biggest Movers From Friday,2019-12-30 04:51:00-05:00,RMTI,neutral
1095409.0,FDA Says Rockwell Medical Webpage Triferic 'False Or Misleading',2019-11-25 15:03:00-05:00,RMTI,negative
1095410.0,UPDATE: Piper Jaffray On Rockwell Medical Notes 'we do remain buyers of RMTI shares as we think this company's new management team remains in a solid position to launch IV Triferic next year',2019-11-12 12:22:00-05:00,RMTI,positive
1095411.0,"UPDATE: Piper Jaffray Maintains Overweight On Rockwell Medical, Lowers Target To $6 Notes 'As Feared, Triferic IV Not TDAPA Eligible; Lowering Estimates Meaningfully'",2019-11-12 12:22:00-05:00,RMTI,negative
1095412.0,"Piper Jaffray Maintains Overweight on Rockwell Medical, Lowers Price Target to $6",2019-11-12 08:39:00-05:00,RMTI,negative
1095413.0,6 Stocks Moving In Monday's After-Hours Session,2019-11-11 17:04:00-05:00,RMTI,neutral
1095414.0,"Rockwell Medical Q3 EPS $(0.12) Beats $(0.16) Estimate, Sales $15.4M Miss $16.02M Estimate",2019-11-11 16:05:00-05:00,RMTI,negative
1095415.0,Stocks That Hit 52-Week Lows On Friday,2019-11-08 11:41:00-05:00,RMTI,negative
1095416.0,"The Daily Biotech Pulse: Obseva Sinks On Adverse Clinical Readout, BioNano Surges On Saphyr Adoption, 2 IPOs",2019-11-07 07:18:00-05:00,RMTI,negative
1095417.0,"The Daily Biotech Pulse: FDA Nod For Sanofi, BioCryst's Edema Drug In Japan, Myriad's Q1 Disappointment",2019-11-05 06:53:00-05:00,RMTI,negative
1095418.0,Stocks That Hit 52-Week Lows On Monday,2019-11-04 14:45:00-05:00,RMTI,negative
1095419.0,Stocks That Hit 52-Week Lows On Friday,2019-11-01 11:13:00-04:00,RMTI,negative
1095420.0,"The Daily Biotech Pulse: Amgen Takes 20.5% Stake In BeiGene, Paratek's Mixed Clinical Readout, CareDx Slips On Guidance",2019-11-01 07:38:00-04:00,RMTI,neutral
1095421.0,Rockwell Medical shares trading lower following worse-than-expected Q3 sales guidance.,2019-10-24 17:09:00-04:00,RMTI,neutral
1095422.0,Rockwell Medical Sees Prelim. Q3 Sales $15M-$15.4M vs $16.9M Est.,2019-10-24 16:48:00-04:00,RMTI,neutral
1095423.0,52 Biggest Movers From Yesterday,2019-10-02 04:22:00-04:00,RMTI,neutral
1095424.0,58 Biggest Movers From Yesterday,2019-09-25 04:54:00-04:00,RMTI,neutral
1095425.0,"Rockwell Medical Q2 EPS $(0.18) Misses $(0.17) Estimate, Sales $14.846M Miss $16.4M Estimate",2019-08-08 16:28:00-04:00,RMTI,negative
1095426.0,"The Daily Biotech Pulse: Glaukos To Buy Avedro, Mixed Adcom Vote For Gilead, Dynavax Offering",2019-08-08 07:11:00-04:00,RMTI,neutral
1095427.0,FDA Accepts Rockwell Medical's New Drug Application,2019-08-06 10:48:00-04:00,RMTI,positive
1095428.0,28 Healthcare Stocks Moving In Today's Pre-Market Session,2019-08-06 08:55:00-04:00,RMTI,neutral
1095429.0,"Rockwell Medical, Inc. Announces FDA  Acceptance New Drug Application For I.V. TRIFERIC",2019-08-06 06:53:00-04:00,RMTI,positive
1095430.0,80 Biggest Movers From Yesterday,2019-07-31 05:28:00-04:00,RMTI,neutral
1095431.0,58 Stocks Moving In Tuesday's Mid-Day Session,2019-07-30 12:39:00-04:00,RMTI,neutral
1095432.0,45 Healthcare Stocks Moving In Monday's After-Market Session,2019-07-30 04:54:00-04:00,RMTI,neutral
1095433.0,"Benzinga's Top Upgrades, Downgrades For June 25, 2019",2019-06-25 09:16:00-04:00,RMTI,positive
1095434.0,"Cantor Fitzgerald Initiates Coverage On Rockwell Medical with Overweight Rating, Announces $11 Price Target",2019-06-25 07:02:00-04:00,RMTI,negative
1095435.0,Rockwell Medical shares are trading higher after Cantor Fitzgerald initiated coverage on the company's stock with a Buy rating and an $11 price target.,2019-06-24 16:18:00-04:00,RMTI,positive
1095436.0,Cantor Fitzgerald Initiates Coverage On Rockwell Medical With Overweight Rating And $11 Price Target,2019-06-24 16:14:00-04:00,RMTI,negative
1095437.0,"Benzinga's Top Upgrades, Downgrades For June 24, 2019",2019-06-24 09:50:00-04:00,RMTI,positive
1095438.0,"Piper Jaffray Initiates Coverage On Rockwell Medical with Overweight Rating, Announces $10 Price Target",2019-06-24 06:31:00-04:00,RMTI,negative
1095439.0,48 Biggest Movers From Yesterday,2019-06-19 04:50:00-04:00,RMTI,neutral
1095440.0,40 Stocks Moving In Tuesday's Mid-Day Session,2019-06-18 12:39:00-04:00,RMTI,neutral
1095441.0,Rockwell Medical shares are trading lower after the company reported a ~5.83 million share offering at $3 per share.,2019-06-18 10:28:00-04:00,RMTI,positive
1095442.0,Mid-Morning Market Update: Markets Open Higher; MoneyGram Shares Jump After Partnering With Ripple,2019-06-18 10:23:00-04:00,RMTI,positive
1095443.0,30 Stocks Moving In Tuesday's Pre-Market Session,2019-06-18 08:29:00-04:00,RMTI,neutral
1095444.0,Rockwell Medical Prices ~5.83M Share Offering At $3/Share,2019-06-18 08:15:00-04:00,RMTI,positive
1095445.0,"The Daily Biotech Pulse: PhaseBio Pumped Up, Eiger Exults On Breakthrough Therapy Designation, Biohaven Slips On Stock Sale",2019-06-18 07:31:00-04:00,RMTI,neutral
1095446.0,A Peek Into The Markets: US Stock Futures Gain Ahead Of Fed Meeting,2019-06-18 07:22:00-04:00,RMTI,positive
1095447.0,"7 Stocks To Watch For June 18, 2019",2019-06-18 04:45:00-04:00,RMTI,neutral
1095448.0,5 Stocks Moving In Monday's After-Hours Session,2019-06-17 16:47:00-04:00,RMTI,neutral
1095449.0,Rockwell Medical shares are trading lower after the company reported a common stock offering with no disclosed size.,2019-06-17 16:07:00-04:00,RMTI,negative
1095450.0,Rockwell Medical Reports Common Stock Offering; Size Not Disclosed,2019-06-17 16:04:00-04:00,RMTI,neutral
1095451.0,A Peek Into The Markets: US Stock Futures Tumble; Dow Futures Down Over 150 Points,2019-05-29 07:18:00-04:00,RMTI,neutral
1095452.0,"Rockwell Medical, Inc. Announces Submission Of New Drug Application For I.V. Triferic",2019-05-29 06:52:00-04:00,RMTI,neutral
1095453.0,"Rockwell Medical Q1 EPS $(0.15) Beats $(0.18) Estimate, Sales $15.6M Miss $16.9M Estimate",2019-05-09 16:37:00-04:00,RMTI,negative
1095454.0,"The Daily Biotech Pulse: Novartis Goes Shopping, Mixed Trial Results For Provention Bio, 4 Stocks To Debut",2019-05-09 07:56:00-04:00,RMTI,neutral
1095455.0,Rockwell Medical Reports Commencement Of Commercial Sales Of Dialysate Triferic In US,2019-05-06 06:51:00-04:00,RMTI,neutral
1095456.0,Shares of several drug companies are trading lower amid continued efforts from Washington to curb prescription drug prices. The overall healthcare sector has seen weakness recently due to uncertainty over the future of healthcare policy.,2019-04-17 10:31:00-04:00,RMTI,negative
1095457.0,60 Biggest Movers From Yesterday,2019-03-19 05:24:00-04:00,RMTI,neutral
1095458.0,"Rockwell Medical Says Auditors Report For Year Ended Dec 31, 2018 Included Paragraph Raising Doubt About Co's Ability To Continue As Going Concern; Says Anticipate Need to Obtain Additional Funding",2019-03-18 06:34:00-04:00,RMTI,negative
1095459.0,"The Daily Biotech Pulse: Arsanis Completes X4 Merger, EC Nod For Roche, Axovant Offering",2019-03-14 07:47:00-04:00,RMTI,neutral
1095460.0,"Rockwell Medical Q4 EPS $(0.17) Misses $(0.13) Estimate, Sales $16.9M Beat $16.1M Estimate",2019-03-14 06:54:00-04:00,RMTI,negative
1095461.0,71 Biggest Movers From Yesterday,2019-02-15 04:59:00-05:00,RMTI,neutral
1095462.0,52 Biggest Movers From Friday,2019-01-22 05:08:00-05:00,RMTI,neutral
1095463.0,58 Biggest Movers From Friday,2019-01-07 04:17:00-05:00,RMTI,neutral
1095464.0,66 Biggest Movers From Yesterday,2019-01-03 05:00:00-05:00,RMTI,neutral
1095465.0,50 Biggest Movers From Monday,2019-01-02 04:48:00-05:00,RMTI,neutral
1095466.0,33 Stocks Moving In Monday's Mid-Day Session,2018-12-31 12:19:00-05:00,RMTI,neutral
1095467.0,"Stocks Which Set New 52-Week Low Yesterday, Tues., Dec. 18, 2018",2018-12-19 12:43:00-05:00,RMTI,negative
1095468.0,"The Daily Biotech Pulse: Puma Aces Late-Stage Trial, Chinese Cheer For FibroGen, J&J $5B Buyback Plan",2018-12-18 08:00:00-05:00,RMTI,positive
1095469.0,"Stocks Which Set New 52-Week Low Yesterday, Mon., Dec. 3, 2018",2018-12-04 09:21:00-05:00,RMTI,negative
1095470.0,"Stocks Which Set New 52-Week Low Yesterday, Thurs., Nov. 29, 2018",2018-11-30 10:27:00-05:00,RMTI,negative
1095471.0,85 Biggest Movers From Friday,2018-11-12 05:16:00-05:00,RMTI,neutral
1095472.0,"Rockwell Medical, Inc. Q3 EPS $(0.10), Same YoY, Sales $16.7M Beat $15M Estimate",2018-11-09 07:11:00-05:00,RMTI,neutral
1095473.0,Rockwell Medical Names Angus Smith CFO,2018-11-01 08:56:00-04:00,RMTI,neutral
1095474.0,"IFS Securities Downgrades Rockwell Medical to Outperform, Announces $11 Price Target",2018-10-19 08:34:00-04:00,RMTI,positive
1095475.0,Rockwell Medical Announces $22M Offering,2018-10-15 08:07:00-04:00,RMTI,neutral
1095476.0,"Rockwell Medical Says Based On Feedback From Pre-NDA Meeting With FDA, It Believes It Has Requirements To Enable FDA To Act On NDA Before End Of 2019",2018-10-12 08:03:00-04:00,RMTI,neutral
1095477.0,60 Biggest Movers From Yesterday,2018-08-16 04:56:00-04:00,RMTI,neutral
1095478.0,"Rockwell Medical Announces a Restatement to Q1 Earnings, Announces Additional $750K Write Down for Inventory, Says Stock-Based Compensation Expenses Were Overstated by $730K, Bonus Accrual Expense Overstated by $1M",2018-08-14 16:44:00-04:00,RMTI,positive
1095479.0,"Rockwell Medical Q2 EPS $(0.24) Misses $(0.13) Estimate, Sales $14.913M Beat $14.9M Estimate",2018-08-14 16:42:00-04:00,RMTI,negative
1095480.0,"Earnings Scheduled For August 14, 2018",2018-08-14 04:32:00-04:00,RMTI,neutral
1095481.0,Rockwell Medical Names Stuart Paul CEO,2018-08-08 08:01:00-04:00,RMTI,neutral
1095482.0,"Rockwell Medical Enters Into Settlement With Robert Chioini, Ronald Boyd, et al, Under Confidential Terms",2018-08-07 12:16:00-04:00,RMTI,neutral
1095483.0,UPDATE: Rockwell Medical Says Co. Does Not Expect Calcitriol Sales To Have Material Impact On FY18 Sales,2018-07-16 08:36:00-04:00,RMTI,neutral
1095484.0,"Rockwell Medical Offers Update On Calcitriol: Received FDA Approval For Prior Approval Supplement For Manufacturing Product On Jul. 11, 2018",2018-07-16 08:35:00-04:00,RMTI,positive
1095485.0,"Rockwell Medical Reports Filing Of Suit In Federal Court Against Former CEO, CFO, Board Member, Current Board Member Boyd, Alleging Mismanagement Of Co.",2018-07-02 17:39:00-04:00,RMTI,neutral
1095486.0,"Benzinga's Daily Biotech Pulse: Gemphire On Fire, Acceleron-Celgene Taste Success, AbbVie Ditches Galapagos",2018-06-29 08:11:00-04:00,RMTI,positive
1095487.0,"Rockwell Medical Provides Investor Update Regarding Its Former CEO, CFO, And Auditor",2018-06-29 07:30:00-04:00,RMTI,neutral
1095488.0,40 Stocks Moving In Thursday's Mid-Day Session,2018-06-28 13:03:00-04:00,RMTI,neutral
1095489.0,42 Biggest Movers From Yesterday,2018-06-28 05:44:00-04:00,RMTI,neutral
1095490.0,26 Stocks Moving In Friday's Pre-Market Session,2018-05-25 08:15:00-04:00,RMTI,neutral
1095491.0,10.9% Owner Richmond Brothers Says Fully Support Decision Made by Rockwell Medical's Board to Terminate Robert Chioini as President & CEO,2018-05-25 06:09:00-04:00,RMTI,positive
1095492.0,"Rockwell Medical 8-K Shows Pres, CEO Robert Chioini Was Terminated; Co. Created Special Transition Committee Including 2 Independent Directors And Current Chair To Provide Direction For Day-To-Day Operations",2018-05-24 16:10:00-04:00,RMTI,positive
1095493.0,"UPDATE: Rockwell Medical CEO Says 8-K Issued By Chairman of the Board Said CFO Thomas Klema Was Terminated, Adding: 'I have no information to suggest the governance requirements to call such a meeting were followed'",2018-05-23 11:30:00-04:00,RMTI,negative
1095494.0,"Rockwell Medical CEO Issues Press Release Reiterating Info From Earlier 8-K Filing Related To May 22nd Emergency Board Meeting, Says Chairman of the Board Issued a Conflicting 8-K",2018-05-23 11:29:00-04:00,RMTI,negative
1095495.0,UPDATE: Nasdaq Says Rockwell Medical Shares Will Remain Halted Until Co. Fully Satisfies Request For Added Info,2018-05-23 10:12:00-04:00,RMTI,positive
1095496.0,Nasdaq Issues Release Highlighting Halt Indication On Rockwell Medical Was Changed To Added Info Requested From Co.,2018-05-23 10:11:00-04:00,RMTI,neutral
1095497.0,Rockwell Medical Shares Halted News Pending,2018-05-23 09:26:00-04:00,RMTI,positive
1095498.0,UPDATE: Rockwell Medical Says Internal Investigation Is Proceeding Under Two Non-conflicted Independent Directors Patrick Bagley and Ronald Boyd,2018-05-23 06:23:00-04:00,RMTI,neutral
1095499.0,Rockwell Medical Says Determination of Non-Conflicted Independent Directors Was That CEO Termination Was Not Effective; Continues to Serve as CEO as per Terms of His Employment Agreement,2018-05-23 06:22:00-04:00,RMTI,positive
1095500.0,Rockwell Medical Announces President and CEO Robert Chioini has been Terminated Effective Immediately,2018-05-22 19:39:00-04:00,RMTI,positive
1095501.0,"Rockwell Medical Q1 EPS $(0.13) Beats $(0.14) Estimate, Sales $14.949M Beat $14.8M Estimate",2018-05-10 17:11:00-04:00,RMTI,neutral
1095502.0,Rockwell Medical Says The FDA Set A Target Date For Response To The Submission For Its Calcitriol Vitamin D Injection For No Later Than Aug. 19th,2018-05-08 08:34:00-04:00,RMTI,neutral
1095503.0,36 Stocks Moving In Friday's Mid-Day Session,2018-03-16 12:35:00-04:00,RMTI,neutral
1095504.0,28 Stocks Moving In Friday's Pre-Market Session,2018-03-16 08:04:00-04:00,RMTI,neutral
1095505.0,"Rockwell Medical Reports Q4 EPS $(0.18) vs $(0.13) Est., Sales $14.8M vs $13.8M Est.",2018-03-15 16:25:00-04:00,RMTI,neutral
1095506.0,Rockwell Medical Q4 Earnings Preview,2018-03-15 10:37:00-04:00,RMTI,neutral
1095507.0,Rockwell Medical Reports Signing Of Exclusive License Deal With Quimica Europea For Commercialization Of Triferic In Peru,2017-12-12 08:32:00-05:00,RMTI,positive
1095508.0,"Rockwell Medical Shares Up 5.622% On Heavy Volume, Reaching Highest Level In 4 Sessions",2017-11-29 15:51:00-05:00,RMTI,positive
1095509.0,"Rockwell Medical Reports Q3 EPS $(0.10) In-line With Est., Sales $14.6M vs $13.35M Est.",2017-11-08 16:41:00-05:00,RMTI,neutral
1095510.0,"Rockwell Reports Q3 EPS $(0.10) vs. $(0.10) Est., Sales $14.6M vs. $13.4M Est.",2017-11-08 16:12:00-05:00,RMTI,neutral
1095511.0,UPDATE: Rockwell Says Expects To Have Answer From FDA In ~4 Months,2017-10-25 08:32:00-04:00,RMTI,neutral
1095512.0,Rockwell Medical Offers Update On Calcitriol Post-Approval Manufacturing Submission To FDA: 'FDA has requested extra time to review its post-approval drug manufacturing submission',2017-10-25 08:32:00-04:00,RMTI,neutral
1095513.0,Rockwell Medical Reports Filing Of Calcitriol Post-Approval Manufacturing Submission With FDA,2017-09-28 08:33:00-04:00,RMTI,neutral
1095514.0,Watch These 5 Huge Put Purchases In Friday Trade,2017-09-15 04:26:00-04:00,RMTI,positive
1095515.0,Rockwell Medical Issues Update On Progress Of Calcitriol Commercial Launch: Suitable For Submission To FDA,2017-09-14 18:11:00-04:00,RMTI,positive
1095516.0,Benzinga's Option Alert Recap From September 14,2017-09-14 16:03:00-04:00,RMTI,positive
1095517.0,Rockwell Med Option Alert: Feb 16 $9 Puts Sweep (14) at the Bid: 500 @ $3.101 vs 500 OI; Ref=$6.4,2017-09-14 12:01:00-04:00,RMTI,positive
1095518.0,Rockwell Medical Says Planning to Submit CMC Supplement to FDA at the End of September 2017,2017-09-13 08:32:00-04:00,RMTI,neutral
1095519.0,"Richmond Brothers Comments on Appointment of John G. Cooper to Rockwell Medical, Inc. Board, Says They Are Cautiously Optimistic That Mr. Cooper Can Bring Sorely-Needed Additional Independent Perspective To Rockwell's Board",2017-09-08 09:01:00-04:00,RMTI,positive
1095520.0,Richmond Brothers And Mark Ravich Says They Are Disappointed That Rockwell Would Make Misleading And Disingenuous Statements Regarding Their Interactions With The Company,2017-08-30 08:31:00-04:00,RMTI,negative
1095521.0,Richmond Brothers Issues Public Letter To Incumbent Directors Of Rockwell Medical,2017-08-29 09:03:00-04:00,RMTI,neutral
1095522.0,Rockwell Medical Issues Response Following Richmond Group 13D Filing Monday,2017-08-29 08:32:00-04:00,RMTI,neutral
1095523.0,Richmond Brothers Seeks Immediate Replacement of Rockwell Medical CEO Robert Chioini -13D/A,2017-08-28 17:33:00-04:00,RMTI,neutral
1095524.0,Hearing IFS Securities Initiates Coverage On Rockwell Medical with Strong Buy Rating,2017-08-14 11:16:00-04:00,RMTI,positive
1095526.0,"ISS, Glass Lewis and Egan Jones Have Now All Recommended That Shareholders Vote on the BLUE Proxy Card For Election Of Mark Ravich To Rockwell Medical Board",2017-05-26 09:01:00-04:00,RMTI,positive
1095527.0,"Richmond Brothers Reports Court Denied Rockwell Medical's Motion for Prelim. Injunction Against Firm, Mark Ravich",2017-05-25 09:01:00-04:00,RMTI,negative
1095528.0,"Richmond Brothers Announces Glass, Lewis Has Recommended Rockwell Medical Holders Vote on BLUE Proxy Card for Firm's Board Nominee Mark Ravich",2017-05-24 09:01:00-04:00,RMTI,positive
1095529.0,Rockwell Medical Issues Letter to Shareholders On Why Electing Mark Ravich Could Do Lasting Harm,2017-05-22 08:21:00-04:00,RMTI,negative
1095530.0,"Richmond Brothers and Mark H. Ravich Issue Letter to Rockwell Medical, Inc. Shareholders, Says Mark Ravich Is Clear Choice TO Be Nomincated To Board At Upcoming Meeting Of Shareholders",2017-05-19 09:02:00-04:00,RMTI,positive
1095531.0,"Richmond Brothers and Mark H. Ravich Urge Rockwell Medical Shareholders to Support Much-Needed Change, Calls On Shareholders To Express Frustration With Management",2017-05-12 09:00:00-04:00,RMTI,negative
1095532.0,"Richmond Brothers and Mark H. Ravich Comment on Rockwell Medical, Inc. First Quarter 2017 Earnings Highlight Lack of Substantive Updates on Key Initiatives and Continued Lack of Results at Rockwell",2017-05-10 09:01:00-04:00,RMTI,negative
1095533.0,"Rockwell Medical REports Q1 EPS $(0.09) vs $(0.09) Est., Sales $14.6M vs $12.6M Est.",2017-05-09 16:04:00-04:00,RMTI,neutral
1095534.0,UPDATE: Richmond Brothers on Rockwell Medical Say to Vote BLUE Proxy for Mark Ravich,2017-04-21 09:05:00-04:00,RMTI,neutral
1095535.0,"UPDATE: Richmond Brothers, Ravich Say 'Believe Change is Needed Urgently to Turn the Tide of Underperformance at Rockwell,' 'Highlight Series of Strategic Missteps and Failures to Execute'",2017-04-21 09:03:00-04:00,RMTI,negative
1095536.0,"Richmond Brothers, Mark Ravich Send Letter to Rockwell Medical Holders",2017-04-21 09:02:00-04:00,RMTI,neutral
1095537.0,"Rockwell Medical Files Definitive Proxy Materials, Highlights Importance Of Electing A Director With Relevant Pharma Expertise; Urges Shareholders To Vote 'For' Rockwell's Director Nominee David Domzalski",2017-04-21 08:32:00-04:00,RMTI,positive
1095538.0,20 Stocks Moving In Thursday's Pre-Market Session,2017-03-30 08:21:00-04:00,RMTI,neutral
1095539.0,"Rockwell Medical Reports ESA Sparing, Compositions, Use Patent Allowed in China",2017-03-28 08:35:00-04:00,RMTI,neutral
1095540.0,"Richmond Brothers and Mark Ravich Believes Rockwell's Lawsuit is a Baseless Waste of Shareholder Money, and Nothing More than an Attempt to Distract Shareholders from Ongoing Underperformance and Failed Execution",2017-03-22 09:06:00-04:00,RMTI,negative
1095541.0,Richmond Brothers & Mark Ravich Say They Are Discouraged By Rockwell's Failure To Execute And The Continued Delay In Bringing Triferic To Market,2017-03-16 09:03:00-04:00,RMTI,negative
1095542.0,"Rockwell Medical Reports Q4 EPS $(0.10) vs. $(0.09) Est., Sales $13.4M vs. $12.01M Est.",2017-03-15 16:02:00-04:00,RMTI,neutral
1095543.0,"Earnings Scheduled For March 15, 2017",2017-03-15 05:42:00-04:00,RMTI,neutral
1095544.0,"Richmond Brothers, Mark Ravich Respond to Rockwell Medical, Inc. Lawsuit; Says they Are Disappointed In Lawsuit Rather Than Engage In Constructive Diaglogue",2017-03-09 09:02:00-05:00,RMTI,negative
1095545.0,"UPDATE: David Richmond Says Rockwell Medical Shares Undervalued Due to Poor Corporate Governance Practices,Operational Missteps by Management Team, Board",2017-02-21 09:09:00-05:00,RMTI,negative
1095546.0,Richmond Brothers Reports 10.8% Stake in Rockwell Medical in 13D,2017-02-21 09:04:00-05:00,RMTI,neutral
1095547.0,Rockwell Medical Says FDA Requested Co. Resubmit Application For New Contract Manufacturer As Prior Approval Supplement And Pay Fee For Agency Review,2017-02-21 09:03:00-05:00,RMTI,positive
1095548.0,18 Biggest Mid-Day Losers For Tuesday,2016-11-08 14:08:00-05:00,RMTI,negative
1095549.0,Stocks Hitting 52-Week Lows,2016-11-08 10:28:00-05:00,RMTI,negative
1095550.0,22 Stocks Moving In Tuesday's Pre-Market Session,2016-11-08 08:34:00-05:00,RMTI,neutral
1095551.0,"Rockwell Medical Reports Q3 EPS $(0.09) vs. Est. $(0.10), Rev. $12.8M vs. Est. $15.4M",2016-11-07 16:04:00-05:00,RMTI,neutral
1095552.0,Amended 13G Filing from Richmond Brothers on Rockwell Medical Shows Raised Stake from ~10.1% as of May 6 to 10.7% Stake,2016-10-12 09:14:00-04:00,RMTI,neutral
1095553.0,Mid-Day Market Update: Rent-A-Center Drops On Disappointing Q3 Outlook; Nymox Shares Surge,2016-10-11 12:27:00-04:00,RMTI,negative
1095554.0,Option Alert: RMTI Nov16 9.0 Calls Sweep: 500 @  ASK  $0.20: 653 traded vs 963 OI:  Earnings 11/14  $6.72 Ref,2016-09-30 15:54:00-04:00,RMTI,positive
1095556.0,"BTIG Sets $12 Price Target On Rockwell Medical, Sees 63% Upside",2016-08-19 12:13:00-04:00,RMTI,neutral
1095557.0,"BTIG Research Initiates Coverage on Rockwell Medical at Buy, Announces $12.00 PT",2016-08-19 07:56:00-04:00,RMTI,neutral
1095558.0,"UPDATE: Rockwell Medical Says Middle East Deal Covers 375K CKD-HD Patients; Co. Has Received Upfront Licensing Fee, High Double Digit Royalty",2016-08-16 08:02:00-04:00,RMTI,neutral
1095559.0,"Rockwell Medical Reports Exclusive License Deal with ARAM Medical to Commercialize Triferic in Saudi Arabia, Egypt, Middle East Territories",2016-08-16 08:01:00-04:00,RMTI,positive
1095560.0,Option Alert: RMTI Aug16 8.0 Calls: 500 @  ASK  $0.55: 500 traded vs 3263 OI:  Earnings 8/2  $7.68 Ref,2016-07-19 10:20:00-04:00,RMTI,positive
1095561.0,"Rockwell Medical To Expand Board From 4 To 5 Directors, Names Dr. Robin Smith To Board",2016-06-23 16:05:00-04:00,RMTI,positive
1095562.0,Mid-Day Market Update: Conn's Drops Following Weak Q1 Results; Achaogen Shares Surge,2016-06-02 12:02:00-04:00,RMTI,negative
1095563.0,Option Alert: RMTI Nov16 12.0 Calls Sweep: 735 @  ASK  $1.35: 846 traded vs 1294 OI: $9.32 Ref,2016-05-26 14:32:00-04:00,RMTI,positive
1095564.0,Rockwell Medical Reports Multiple Int'l Trademark Approval for Triferic,2016-05-12 08:06:00-04:00,RMTI,positive
1095565.0,"Rockwell Medical Reports Q1 EPS $(0.10) vs. Est. $(0.08), Rev. $13.6M vs. Est. $15.25M",2016-05-10 16:02:00-04:00,RMTI,neutral
1095566.0,U.S. FDA Approves Rockwell's Triferic Powder Packet for Treating Anemia in Hemodialysis Patients,2016-04-26 08:01:00-04:00,RMTI,positive
1095567.0,Rockwell Medical Shares Falling,2016-04-06 12:22:00-04:00,RMTI,positive
1095568.0,10 Stocks Moving In Monday's Pre-Market Session,2016-03-21 08:22:00-04:00,RMTI,neutral
1095569.0,"China FDA Accepts Rockwell Medical's Triferic Drug Submission for Commercialization in China, Initiates Process For Drug Approval In Chinese Dialysis Market",2016-03-21 08:02:00-04:00,RMTI,positive
1095570.0,6 Stocks Trending In Short-Seller Circles: From Tesla To Fitbit,2016-03-02 16:13:00-05:00,RMTI,neutral
1095571.0,Mid-Afternoon Market Update: American Public Education Rises Following Q4 Results; PTC Therapeutics Shares Fall,2016-03-01 14:26:00-05:00,RMTI,positive
1095572.0,Mid-Day Market Update: Dow Jumps Over 250 Points; Rockwell Medical Shares Decline On Weak Q4 Results,2016-03-01 12:20:00-05:00,RMTI,negative
1095573.0,Mid-Morning Market Update: Markets Open Higher; Dollar Tree Misses Q4 Views,2016-03-01 10:11:00-05:00,RMTI,negative
1095574.0,Rockwell Medical Is Getting Killed Because Of These Numbers,2016-03-01 09:31:00-05:00,RMTI,negative
1095575.0,10 Stocks Moving In Tuesday's Pre-Market Session,2016-03-01 08:24:00-05:00,RMTI,neutral
1095576.0,Craig-Hallum Downgrades Rockwell Medical to Hold,2016-03-01 07:40:00-05:00,RMTI,neutral
1095577.0,Stifel Nicolaus Downgrades Rockwell Medical to Hold,2016-03-01 06:55:00-05:00,RMTI,neutral
1095578.0,"7 Must Watch Stocks for March 1, 2016",2016-03-01 04:24:00-05:00,RMTI,neutral
1095579.0,7 Stocks Moving In Today's After-Hours Session,2016-02-29 18:01:00-05:00,RMTI,neutral
1095580.0,"Rockwell Medical Q4 EPS -$0.12 vs $0.02 est, Revenue $14.1M vs $20.0M est",2016-02-29 16:02:00-05:00,RMTI,neutral
1095581.0,10 Stocks Moving In Monday's Pre-Market Session,2016-02-29 08:25:00-05:00,RMTI,neutral
1095582.0,Rockwell Medical Spikes to High of $10.50,2016-02-26 11:53:00-05:00,RMTI,neutral
1095583.0,Rockwell Medical Spikes to High of $8.95,2016-02-25 15:22:00-05:00,RMTI,neutral
1095584.0,"Rockwell Medical, GoPro, Inovio And Other Hot Stocks In Short-Selling Circles",2016-02-25 11:04:00-05:00,RMTI,neutral
1095585.0,Rockwell Medical Spikes to High of $8.45,2016-02-23 15:44:00-05:00,RMTI,neutral
1095586.0,"Rockwell Medical Announces Filing of IND to Investigate Triferic for Rare Opphan Disease Iron-Refractory, Iron-Deficiency Anemia",2016-02-22 08:13:00-05:00,RMTI,neutral
1095587.0,"Rockwell Medical Files IND to Investigate Triferic for Rare Orphan Disease Iron-Refractory, Iron-Deficiency Anemia",2016-02-22 08:03:00-05:00,RMTI,neutral
1095588.0,"Rockwell Medical, Wanbang Biopharma Enter Exclusive License Agreement For Commercialization Of Triferic in China",2016-02-16 08:02:00-05:00,RMTI,positive
1095589.0,Mid-Afternoon Market Update: Crude Oil Climbs 6%; Sprint Shares Gain Following Strong Q3 Earnings,2016-01-26 14:40:00-05:00,RMTI,positive
1095590.0,Rockwell Medical's Triferic Receives Permanent J-Code for Renal Drug Reimbursement,2015-11-30 08:02:00-05:00,RMTI,neutral
1095591.0,"Rockwell Medical Earlier Reports Q3 EPS $(0.05) vs. Est. $(0.02), Rev. $14.4M vs. Est. $14.93M",2015-11-09 16:52:00-05:00,RMTI,neutral
1095592.0,Why Oppenheimer Still Thinks Rockwell Medical Could Double,2015-10-21 16:29:00-04:00,RMTI,neutral
1095593.0,Rockwell Medical Announces Four Triferic Posters Accepted for Presentation at American Society of Nephrology (ASN) Clinical Meeting November 2015,2015-10-06 08:07:00-04:00,RMTI,positive
1095594.0,Oppenheimer's Still Buying Rockwell Medical: Channel Checks And Insider Buying Explain Why,2015-08-21 08:47:00-04:00,RMTI,neutral
1095595.0,"Rockwell Medical  VP Pratt Buys 5,000 Shares @$11.54/Share -Form 4",2015-08-14 09:37:00-04:00,RMTI,positive
1095596.0,Mid-Morning Market Update: Markets Decline; Kohl's Misses Q2 Views,2015-08-13 10:36:00-04:00,RMTI,negative
1095597.0,Morning Market Losers,2015-08-13 09:54:00-04:00,RMTI,negative
1095598.0,Morgan Stanley: Time To Sell Rockwell Medical,2015-08-13 08:18:00-04:00,RMTI,neutral
1095599.0,"Morgan Stanley Initiates Coverage on Rockwell Medical at Underweight, Announces $7.00 PT",2015-08-13 04:38:00-04:00,RMTI,neutral
1095600.0,Rockwell Medical Reports Q2 Loss of $0.05/Share vs Loss of $0.10/Share Est.,2015-08-04 16:24:00-04:00,RMTI,negative
1095601.0,Rockwell Medical Reports Triferic Phase 3 CRUISE Studies Published in Nephrology Dialysis Transplantation,2015-07-15 08:00:00-04:00,RMTI,neutral
1095602.0,Bank of America Reinstates Neutral on Rockwell Medical,2015-07-08 08:31:00-04:00,RMTI,neutral
1095603.0,These 3 Stocks Are Seeing Short-Selling Activity Rise,2015-07-07 13:44:00-04:00,RMTI,neutral
1095604.0,Benzinga's Volume Movers,2015-06-25 10:26:00-04:00,RMTI,neutral
1095605.0,Biotech Pair Trade? Brean Weighs In On Keryx Biopharma And Rockwell Medical,2015-06-23 12:07:00-04:00,RMTI,neutral
1095606.0,Rockwell Medical Shares Indicated Very Slightly Lower Post Market Following S-3 Showing Registration for $200M Mixed Securities Shelf Offering,2015-06-02 17:10:00-04:00,RMTI,positive
1095607.0,Rockwell Medical Reports Triferic Clinical Data Selected for Four Presentations at 52nd ERA-EDTA Congress May 28-31 in London,2015-05-12 08:05:00-04:00,RMTI,neutral
1095608.0,8 Oppenheimer Analysts Choose Their Favorite Healthcare Stocks,2015-03-31 12:04:00-04:00,RMTI,positive
1095609.0,Rockwell Medical Q4 Losses Wider Than Expected,2015-02-26 16:46:00-05:00,RMTI,negative
1095610.0,Rockwell Medical Reports Q4 EPS $(0.14),2015-02-26 16:15:00-05:00,RMTI,neutral
1095611.0,"8-K: Rockwell Medical Terminates, Pays Loan And Security Agreement With Hercules Tech.",2015-01-28 11:40:00-05:00,RMTI,positive
1095612.0,Brean Predicts 'A Skid And A Crash' For Rockwell Medical's Triferic Drug,2015-01-26 16:25:00-05:00,RMTI,negative
1095613.0,Adam Feuerstein @adamfeuerstein Tweet: I've read many FDA drug labels in my days. Triferic's is among the worst in terms of providing zero helpful info to treating docs. $RMTI,2015-01-26 12:46:00-05:00,RMTI,negative
1095614.0,Benzinga's Volume Movers,2015-01-26 10:30:00-05:00,RMTI,neutral
1095615.0,Hearing Brean Cautious on Rockwell Medical,2015-01-26 10:10:00-05:00,RMTI,negative
1095616.0,Why Shares Of Rockwell Medical Are Up Huge,2015-01-26 10:01:00-05:00,RMTI,positive
1095617.0,Morning Market Gainers,2015-01-26 09:43:00-05:00,RMTI,neutral
1095618.0,Rockwell Medical Shares Rise 19% Premarket on FDA Approval of Triferic,2015-01-26 08:38:00-05:00,RMTI,positive
1095619.0,Benzinga's Top #PreMarket Losers,2015-01-26 08:22:00-05:00,RMTI,negative
1095620.0,PREVIEW: Rockwell Medical Shares to Resume Trading at 8:30 AM ET,2015-01-26 08:15:00-05:00,RMTI,positive
1095621.0,"Rockwell Medical Reports FDA Approval of Triferic for Iron Replacement, Maintenance of Hemoglobin in Hemodialysis Patients",2015-01-26 08:01:00-05:00,RMTI,positive
1095622.0,Rockwell Medical Shares Halted News Pending,2015-01-26 07:50:00-05:00,RMTI,positive
1095623.0,What Investors Should Expect From Rockwell Medical's Next FDA Decision,2015-01-07 16:22:00-05:00,RMTI,neutral
1095624.0,Benzinga's Top Initiations,2015-01-07 09:20:00-05:00,RMTI,positive
1095625.0,Oppenheimer Initiates Rockwell Medical With Outperform,2015-01-07 09:04:00-05:00,RMTI,neutral
1095626.0,UPDATE: Oppenheimer Initiates Coverage On Rockwell Medical On Significant Expected Upside,2015-01-07 08:56:00-05:00,RMTI,positive
1095627.0,Biotech Stocks Make Big Moves In Final Days Of 2014,2014-12-31 09:41:00-05:00,RMTI,neutral
1095628.0,Brean Capital's Top Ideas For 2015,2014-12-26 18:05:00-05:00,RMTI,positive
1095629.0,Mid-Day Market Update: U.S. Stocks Turn Higher; Williams-Sonoma Shares Climb On Earnings Beat,2014-11-20 12:38:00-05:00,RMTI,positive
1095630.0,Mid-Morning Market Update: Markets Mixed; Dollar Tree Posts Upbeat Earnings,2014-11-20 11:28:00-05:00,RMTI,neutral
1095631.0,Rockwell Medical Shares Fall ~7% Premarket on Pricing of 6.5M Share Offering @$9.00/Share,2014-11-20 08:36:00-05:00,RMTI,positive
1095632.0,Rockwell Medical Prices 6.5M Share Offering @$9.00/Share,2014-11-20 05:12:00-05:00,RMTI,positive
1095633.0,Rockwell Medical Announces $55M Proposed Public Offering of Common Stock,2014-11-17 16:16:00-05:00,RMTI,neutral
1095634.0,"Rockwell Medical, Inc. Reports Q3 EPS of $(0.10), Inline; Revenue of $13.70M vs $13.36M Est",2014-11-10 16:24:00-05:00,RMTI,neutral
1095635.0,"Earnings Scheduled For November 10, 2014",2014-11-10 05:36:00-05:00,RMTI,neutral
1095636.0,Benzinga's Volume Movers,2014-11-07 10:51:00-05:00,RMTI,neutral
1095637.0,"Chardan Capital Maintains Buy on Rockwell Medical, Inc., Raises PT to $27.00",2014-11-07 10:31:00-05:00,RMTI,neutral
1095638.0,Morning Market Movers ,2014-11-07 09:42:00-05:00,RMTI,neutral
1095639.0,Benzinga's Top #PreMarket Gainers,2014-11-07 08:13:00-05:00,RMTI,positive
1095640.0,Rockwell Medical Shares Rise 35% After-Hours as FDA Oncologic Drugs Advisory Committee Voted In Favor Of Triferic 8 To 3,2014-11-06 19:50:00-05:00,RMTI,positive
1095641.0,Rockwell Medical Reports FDA Panel Has Recommended Triferic,2014-11-06 18:26:00-05:00,RMTI,positive
1095642.0,Rockwell Medical Halted As FDA Review Triferic,2014-11-06 12:53:00-05:00,RMTI,neutral
1095643.0,Rockwell Medical Halted,2014-11-06 12:51:00-05:00,RMTI,neutral
1095644.0,Adam Feuerstein @adamfeuerstein Tweet: FDA posted a new document with voting questions for $RMTI panel. They read more negative -> fda.gov/downloads/Advi…,2014-11-04 12:30:00-05:00,RMTI,negative
1095645.0,Adam Feuerstein/Street.com Article: 'FDA Review of Rockwell's Dialysis Therapy Raises Doubts About Need' Ahead of Thursday Panel,2014-11-04 10:27:00-05:00,RMTI,negative
1095646.0,"Rockwell Medical Shares Rise 11% Ahead of FDA Oncologic Drugs Advisory Committee Meeting to Review NDA for Triferic on Thursday November 6, 2014",2014-11-04 10:14:00-05:00,RMTI,positive
1095647.0,Rockwell Medical Announces FDA Advisory Committee Review Of Triferic For The Treatment Of Iron Replacement And Maintenance Of Hemoglobin In Hemodialysis Patients,2014-10-09 07:31:00-04:00,RMTI,neutral
1095648.0,Benzinga's Top #PreMarket Gainers,2014-10-03 08:44:00-04:00,RMTI,positive
1095649.0,"UPDATE: Rockwell Medical Will Receive $20M in Upfront Cash, $15M Investment Through Stock from Baxter",2014-10-03 07:16:00-04:00,RMTI,neutral
1095650.0,Rockwell Medical Reports Exclusive Long-Term Deal with Baxter for Commercialization of Hemodialysis Concentrates,2014-10-03 07:03:00-04:00,RMTI,positive
1095651.0,Stocks Hitting 52-Week Lows,2014-10-01 10:12:00-04:00,RMTI,negative
1095652.0,Morning Market Movers ,2014-09-11 09:37:00-04:00,RMTI,neutral
1095653.0,Benzinga's Top #PreMarket Gainers,2014-09-11 08:04:00-04:00,RMTI,positive
1095654.0,Morning Market Losers ,2014-08-14 09:47:00-04:00,RMTI,negative
1095655.0,Benzinga's Top #PreMarket Losers ,2014-08-14 08:13:00-04:00,RMTI,negative
1095656.0,"FBR Capital Initiates Coverage on Rockwell Medical, Inc. at Underperform, Announces $6.00 PT",2014-08-14 06:25:00-04:00,RMTI,neutral
1095657.0,Rockwell Medical EPS -$0.08 vs -$0.12 Estimate,2014-07-31 16:04:00-04:00,RMTI,neutral
1095658.0,Rockwell Media Says FDA will Refund $2.2M For NDA,2014-06-30 08:13:00-04:00,RMTI,neutral
1095659.0,Benzinga's Volume Movers,2014-06-23 10:30:00-04:00,RMTI,neutral
1095660.0,Morning Market Movers ,2014-06-23 09:38:00-04:00,RMTI,neutral
1095661.0,Rockwell Medical Announces FDA Approval for Calcitriol,2014-06-23 08:05:00-04:00,RMTI,positive
1095662.0,Rockwell Medical Announces FDA Acceptance of Filing For Triferic New Drug Application,2014-05-28 08:01:00-04:00,RMTI,positive
1095663.0,"Rockwell Medical, Inc. Reports Q1 EPS of $(0.20) vs $(0.14) Est; Revenue of $13.0M vs $14.22M Est",2014-05-12 16:10:00-04:00,RMTI,neutral
1095664.0,"Rockwell Medical, Inc. Reports Q4 EPS of $(0.21) vs $(0.28) Est; Revenue of $14.0M vs $14.04M Est",2014-02-26 16:03:00-05:00,RMTI,neutral
1095665.0,Rockwell Medical Receives Japanese Patent Issuance for Triferic(TM) GMP Formulation ,2014-02-21 08:34:00-05:00,RMTI,neutral
1095666.0,Rockwell Medical Receives Japanese Patent Issuance for Triferic,2014-02-21 08:31:00-05:00,RMTI,neutral
1095667.0,Benzinga's Top #PreMarket Gainers,2014-02-14 08:12:00-05:00,RMTI,positive
1095668.0,Rockwell Medical Spikes Higher,2014-02-12 11:24:00-05:00,RMTI,neutral
1095669.0,"Chardan Capital Initiates Coverage on Rockwell Medical, Inc. at Buy, Announces $22.00 PT",2013-12-19 08:48:00-05:00,RMTI,neutral
1095670.0,Market Wrap For December 17: Markets Relatively Calm Before The Potential Storm,2013-12-17 16:51:00-05:00,RMTI,positive
1095671.0,Mid-Afternoon Market Update: Markets Mixed as iRobot Surges,2013-12-17 15:24:00-05:00,RMTI,neutral
1095672.0,Hearing Craig-Hallum Positive on Rockwell Medical ,2013-12-17 12:03:00-05:00,RMTI,positive
1095673.0,"Rockwell Shares Sink 25% After Brean Sets New Sell Rating, $4 Price Target, Voices Concern on Triferic",2013-12-17 11:53:00-05:00,RMTI,positive
1095674.0,Morning Market Losers ,2013-12-17 10:01:00-05:00,RMTI,negative
1095675.0,Benzinga's Top #PreMarket Losers,2013-12-17 08:28:00-05:00,RMTI,negative
1095676.0,Benzinga's Top Initiations,2013-12-17 08:10:00-05:00,RMTI,positive
1095677.0,"Brean Capital Initiates Coverage on Rockwell Medical, Inc. at Sell, Announces $4.00 PT",2013-12-16 18:00:00-05:00,RMTI,neutral
1095678.0,"Rockwell Medical, Inc. Reports Q3 EPS of $(0.34) vs $(0.24) Est; Revenue of $13.10M vs $13.68M Est",2013-11-05 16:43:00-05:00,RMTI,neutral
1095679.0,Rockwell Medical Announces Clean Safety Results From Triferic Short-Term Safety Study,2013-10-21 08:25:00-04:00,RMTI,positive
1095680.0,Mid-Day Market Update: Global Payments Gains On Upbeat Results; Team Shares Dip,2013-10-02 12:59:00-04:00,RMTI,positive
1095681.0,Benzinga's Volume Movers,2013-10-02 10:26:00-04:00,RMTI,neutral
1095682.0,Mid-Morning Market Update: Markets Slip; Monsanto Reports Wider Loss,2013-10-02 10:24:00-04:00,RMTI,negative
1095683.0,Rockwell Medical Says Phase 3 CRUISE Data Accepted as Late-Breaking Trial Abstract,2013-10-02 08:05:00-04:00,RMTI,positive
1095684.0,Hearing Brean Murray Negative Comments on Rockwell Medical Saying Drug May Not be Approved,2013-10-01 09:46:00-04:00,RMTI,negative
1095685.0,"Rockwell Medical Shares Breaking Out; Price Pushed Over 200-Day SMA Following Three Failed Tests of That Indicator, Now Up 4%",2013-09-26 12:38:00-04:00,RMTI,negative
1095686.0,Rockwell Medical Spikes Higher,2013-09-26 12:28:00-04:00,RMTI,neutral
1095687.0,Rockwell Medical Shares Strong Again Today; May be Attributed to Speculation of Calcitriol Manufacturing Approval Announcement,2013-09-24 12:01:00-04:00,RMTI,positive
1095688.0,Rockwell Medical Spikes Higher,2013-09-24 11:35:00-04:00,RMTI,neutral
1095689.0,Rockwell Medical Reports FDA Acceptance of Triferic as Proprietary Trade Name for Investigational Iron-Delivery Drug SFP,2013-09-17 08:01:00-04:00,RMTI,positive
1095690.0,Stocks Hitting 52-Week Highs,2013-09-13 10:19:00-04:00,RMTI,neutral
1095691.0,"Craig-Hallum Initiates Coverage on Rockwell Medical, Inc. at Buy, Announces $16.00 PT",2013-09-13 09:05:00-04:00,RMTI,neutral
1095692.0,Stocks Hitting 52-Week Highs,2013-09-06 10:06:00-04:00,RMTI,neutral
1095693.0,"Investors in Rockwell Medical Cheer as Analyst Lifts Price Target to $25, Representing 200+% Upside",2013-09-05 14:28:00-04:00,RMTI,positive
1095694.0,Benzinga's Top Pre-Market Gainers,2013-09-04 08:07:00-04:00,RMTI,positive
1095695.0,Rockwell Medical Announces SFP Phase 3 Efficacy Study CRUISE-2 Completes Patient Dosing,2013-07-22 08:00:00-04:00,RMTI,neutral
1095696.0,Hearing Negative Ladenburg Note on Rockwell Medical SFP Data,2013-07-16 10:36:00-04:00,RMTI,negative
1095697.0,Benzinga's Top Pre-Market Gainers,2013-07-12 08:14:00-04:00,RMTI,positive
1095698.0,"Market Wrap for Thursday, July 11: Market Jumps on Dovish Bernanke Comments ",2013-07-11 16:14:00-04:00,RMTI,neutral
1095699.0,Benzinga's Top Pre-Market Gainers,2013-07-11 08:13:00-04:00,RMTI,positive
1095700.0,Rockwell Medical Shares Rise 41% Pre-Market on Positive Phase 3 SFP Data,2013-07-11 07:07:00-04:00,RMTI,positive
1095701.0,Rockwell Medical SFP Meets Primary and Key Secondary Endpoints in Phase 3 CRUISE-1 Efficacy Study,2013-07-11 06:54:00-04:00,RMTI,neutral
1095702.0,Rockwell Medical to Discuss Top-Line Results From SFP Phase 3 CRUISE-1 Efficacy Study ,2013-07-10 16:03:00-04:00,RMTI,neutral
1095703.0,Rockwell Medical Announces $20M in New Financing,2013-06-18 08:02:00-04:00,RMTI,neutral
1095704.0,Rockwell Medical Announces SFP Phase 3 Efficacy Study CRUISE-1 Completes Patient Dosing ,2013-05-29 08:05:00-04:00,RMTI,neutral
1095705.0,Rockwell Medical Closes $40.3M Share Offering,2013-05-20 14:37:00-04:00,RMTI,positive
1095706.0,Rockwell Medical Says Iron Drug SFP Met Primary Endpoint,2013-05-20 08:05:00-04:00,RMTI,neutral
1095707.0,Rockwell Medical Prices 11.5M Shares at $3.05/Share,2013-05-15 07:04:00-04:00,RMTI,positive
1095708.0,"Stifel Nicolaus Maintains Buy on Rockwell Medical, Inc., Lowers PT to $11.00",2013-05-09 08:39:00-04:00,RMTI,negative
1095709.0,"Rockwell Medical, Inc. Reports Q1 EPS of $(0.72) vs $(0.48) Est; Revenue of $12.30M vs $13.07M Est",2013-05-08 17:15:00-04:00,RMTI,neutral
1095710.0,Rockwell Medical Issues Calcitriol Manufacturing Data to FDA for Approval,2013-04-01 08:02:00-04:00,RMTI,positive
1095711.0,Rockwell Medical Sells 4.3M Shares at $3/Share,2013-03-26 09:16:00-04:00,RMTI,positive
1095712.0,Stocks Hitting 52-Week Lows,2013-03-20 10:22:00-04:00,RMTI,negative
1095713.0,Rockwell Medical Prices 4.3M Shares at $3/Share for Proceeds $12M,2013-03-20 09:11:00-04:00,RMTI,positive
1095714.0,Stocks Hitting 52-Week Lows,2013-03-19 10:20:00-04:00,RMTI,negative
1095715.0,"Rockwell Medical, Inc. Reports Q4 EPS of $(0.66), Inline; Revenue of $13.0M vs $13.04M Est",2013-03-18 16:03:00-04:00,RMTI,neutral
1095716.0,"Earnings Scheduled For March 18, 2013",2013-03-18 04:09:00-04:00,RMTI,neutral
1095717.0,Stocks Hitting 52-Week Lows,2013-02-21 10:39:00-05:00,RMTI,negative
1095718.0,"Option Alert: Rockwell Medical Call Volume at 3,924% of Average; Currently $6.70",2013-02-04 12:44:00-05:00,RMTI,positive
1095719.0,Benzinga's Top Pre-Market Gainers,2013-02-04 08:21:00-05:00,RMTI,positive
1095720.0,Benzinga's Top Pre-Market Gainers,2013-02-04 08:17:00-05:00,RMTI,positive
1095721.0,Benzinga's Top Pre-Market Gainers,2013-02-04 08:17:00-05:00,RMTI,positive
1095722.0,Benzinga's Top Pre-Market Gainers,2013-02-04 08:17:00-05:00,RMTI,positive
1095723.0,UPDATE: Dawson James Initiates Rockwell Medical at Market Outperform on Execution  ,2012-11-27 14:01:00-05:00,RMTI,neutral
1095724.0,"Dawson James Initiates Coverage Rockwell Medical Technologies at Outperform, Announces PT of $12",2012-11-27 06:36:00-05:00,RMTI,neutral
1095725.0,UPDATE: Stifel Nicolaus Cuts PT to $13 on Rockwell Medical Technologies on Weak EPS  ,2012-11-09 13:55:00-05:00,RMTI,negative
1095726.0,"Stifel Nicolaus Maintains Rockwell Medical Technologies at Buy, Lowers PT from $15 to $13",2012-11-09 08:56:00-05:00,RMTI,negative
1095727.0,Rockwell Medical Receives Canadian Patent for SFP Formulation for Iron-Delivery in Hemodialysis Patients ,2012-08-28 07:30:00-04:00,RMTI,neutral
1095728.0,Rockwell Medical Technologies Reports Q2 EPS $-0.58 vs $-0.50 Est; Revenues $12.1M vs $12.38M Est,2012-08-07 07:45:00-04:00,RMTI,neutral
1095729.0,Rockwell Medical Announces Canadian Patent Issuance for Proprietary SFP-Iron Delivery  ,2012-06-27 07:30:00-04:00,RMTI,neutral
1095730.0,Rockwell's Former Drug Developer Accuses Company of Reporting False Information,2012-06-20 11:14:00-04:00,RMTI,negative
1095731.0,Rockwell Medical Tech Seeing Weakness after Negative ShareSleuth Article,2012-06-20 09:15:00-04:00,RMTI,negative
1095732.0,Rockwell Medical Announces European Patent Issuance for Proprietary SFP Formulation  ,2012-05-21 07:33:00-04:00,RMTI,neutral
1095733.0,"Morning Social Media Outlook for Thursday April 12 (RMTI, FORM, AVID, CSC)",2012-04-12 10:30:00-04:00,RMTI,positive
1095734.0,"Summer Street Research Partners Initiates Coverage on Rockwell Medical Technologies at Buy, ann PT to $20",2012-04-11 13:53:00-04:00,RMTI,neutral
1095735.0,Rockwell Medical Data Safety Monitoring Board Recommends SFP Phase III Efficacy Studies to Continue as Planned ,2012-03-19 07:02:00-04:00,RMTI,positive
1095736.0,"Stifel Nicolaus Initiates Coverage on Rockwell Medical Technologies at Buy, Announces PT of $15",2012-03-12 11:19:00-04:00,RMTI,neutral
1095737.0,"UPDATE: Stifel Nicolaus Initiates Buy, $15 Target on Rockwell Medical Technologies",2012-03-12 09:35:00-04:00,RMTI,neutral
1095738.0,"Stifel Nicolaus Initiates Coverage on Rockwell Medical Technologies at Buy, Announces  from $15 to $pt",2012-03-12 08:19:00-04:00,RMTI,neutral
1095739.0,Rockwell Medical Closes $17.5 million Registered Common Stock Offering ,2012-02-15 16:22:00-05:00,RMTI,neutral
1095740.0,Rockwell Medical Prices Registered 1.845M Share Offering at $9.50  ,2012-02-10 06:53:00-05:00,RMTI,positive
1095741.0,Rockwell Medical Data Safety Monitoring Board Recommends Phase III CRUISE Studies Continue as Planned  ,2011-12-12 07:32:00-05:00,RMTI,positive
1095742.0,"McNicoll, Lewis & Vlak Reiterates Rockwell Medical Buy, $16.50 PT",2011-08-05 12:18:00-04:00,RMTI,neutral
1095743.0,Rockwell Medical Announces Acquisition of Generic Drug Vitamin-D to Treat Secondary Hyperparathyroidism in ESRD Patients,2011-07-26 07:37:00-04:00,RMTI,positive
1095744.0,UPDATE: Wedbush Raises PT on Rockwell Medical Technologies to $17,2011-07-07 08:07:00-04:00,RMTI,neutral
1095745.0,Wedbush Raises PT On Rockwell Medical Technologies To $17,2011-07-07 07:25:00-04:00,RMTI,neutral
1095746.0,Rockwell Medical Gains Membership Into the Russell 2000 Index,2011-06-29 07:32:00-04:00,RMTI,positive
1095747.0,Stocks to Watch for 6/14/11: Fresh 52-Week Highs and Lows,2011-06-14 04:15:00-04:00,RMTI,positive
1095748.0,Bacterin and Rockwell Medical Join Russell Index,2011-06-13 10:18:00-04:00,RMTI,positive
1095749.0,Bacterin is a Biotech Heading Towards Profitability,2011-05-30 12:05:00-04:00,RMTI,positive
1095750.0,Rockwell Medical Announces New Supply Agreement With DaVita Inc.  ,2011-03-28 07:43:00-04:00,RMTI,positive
1095751.0,Rockwell Medical Starts Pivotal Phase III Clinical Study for Treatment of Iron Deficiency in Dialysis Patients  ,2011-03-24 07:41:00-04:00,RMTI,neutral
1095752.0,"Top Narrow Based Indexes For September 21 (TTPA, URRE, RMTI)",2010-09-21 15:56:00-04:00,RMTI,positive
1095753.0,"Benzinga’s Top Pre-Market Gainers (OSIP, BIOD, ARIA, RMTI, DISH)",2010-03-01 08:22:00-05:00,RMTI,positive
1095754.0,"Biggest Losers (CIT,ICON,RGN,LUNA,RMTI)",2009-09-30 12:10:00-04:00,RMTI,negative
